Japan’s Nikkei closed its best week in three months thanks to the hope of achieving a commercial agreement with the US

Japan’s Nikkei closed its best week in three months thanks to the hope of achieving a commercial agreement with the US

The average of actions Japan Nikkei It rose 1% on Friday, which marked its best week in three months, given the growing optimism of investors that the US president Donald Trump He can realize trade agreements with some of his main partners, including Japan.

The Nikkei (.N225) index touched a maximum of two weeks of 34,758.97 before closing with an increase of 1.03% in 34,730.28, despite a moderate volume of operations due to Holy Week holidays in most other markets. The widest Topix (.topx) index won 1.14%.

In the weekly accumulated, the Nikkei rose 3.4%, its best yield since January 20, breaking a three -week running streak of losses.

Trump’s peace

On Thursday, Trump and his close ally, the Italian Prime Minister Giorgia Meloni, expressed optimism regarding the resolution of commercial tensions between the United States and the European Union. Trump also gave signs of a possible end to tariff climbing with China.

A day before, the main negotiator of Japan, Economy Minister Ryosei Akazawa, initiated a dialogue in Washington and then told the press that Trump had told him that achieving an agreement with Japan was a “maximum priority.” The former president praised conversations on his social networks, stating that there was “great progress!”

Markets-Tokio-Nikkei-Actions-Bolsas-Inversiones-Finance

Impulse for the Nikkei: it rises 3.4% in the week in the face of advances in Trump negotiations.

Reuters

“The general atmosphere was quite positive, underlined by Trump’s publication on social networks with a smiling photo with Akazawa in the oval office,” said James Brady, vice president of the firm of advice Teneo.

“The general perception is that discussions began reasonably good.”

The shipping sector (.iship.t) was the second with the best performance among the 33 industrial groups of the Tokyo Stock Exchange, with a gain of 2.92%.

The pharmaceutical sector (.ipham.t) led the rises with a leap of 4.68%, driven by a 17.54% rise in the actions of Pharmaceutical Chugai (4519.T), after a medication against obesity that developed and licensed Eli Lilly showed good results in clinical trials.

However, the actions of the semiconductor sector struck the Nikkei, since investors resumed sales after Thursday’s rebound.

Source: Ambito

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest Posts